ImmunityBio, the developer of bladder cancer treatment Anktiva, is accused by the U.S. Food and Drug Administration of disseminating “false or misleading information” about the drug's efficacy in an advertisement and podcast. The FDA said it’s not the first time it's sent a warning letter to the company’s executives over allegedly inaccurate claims.

U.S. healthcare will know it’s gotten AI right when the technology demonstrably improves care access, attentiveness and outcomes for the least financially healthy among us. 

A new acellular tissue-engineered vessel developed by Vascudyne could provide surgeons with a safe, effective alternative to saphenous vein grafts.

Several U.S. medical societies have collaborated on a new report advocating for better safety standards in cardiac catheterization labs. As one cardiologist described it, clinicians have shifted from "accepting risk" to "expecting better."

Successfully adopting the technology across wide and varying care settings depends on a whole lot more than just technical sophistication. 

Targeting key cardiovascular risk factors for two full years was not linked to a reduced risk of cognitive decline or dementia.

The COVID-19 pandemic created a major shift in how telehealth services were being utilized. Those services were used much more often for some patient populations than others.

The federal regulatory agency that exists to protect consumers and promote competition across the economy is newly focused on patients and clinicians as well as taxpayers.